Market Place
Sourcing Support
All News #Library
Others
Lipella Pharmaceuticals Delists from Nasdaq Market
20 Jun 2025 //
GLOBENEWSWIRE
Lipella Pharma to Present at 2024 Maxim Healthcare Virtual Summit
09 Oct 2024 //
GLOBENEWSWIRE
Lipella Pharmaceuticals To Attend H.C. Wainwright Investment Conference
27 Aug 2024 //
GLOBENEWSWIRE
Lipella Pharma Launches Registry For Oral Lichen Planus Research
22 Aug 2024 //
GLOBENEWSWIRE
Lipella Completes Site Initiation For LP-310 Phase 2a In Oral Lichen
31 May 2024 //
GLOBENEWSWIRE
Lipella Presents Abstract At 2024 ASCO Annual Meeting
29 May 2024 //
GLOBENEWSWIRE
Lipella To Advance Lead To Phase 2b After FDA Guidance
21 May 2024 //
GLOBENEWSWIRE
Lipella Pharmaceuticals Expands Advisory Board with Oncology Experts
17 Apr 2024 //
GLOBENEWSWIRE
Lipella Pharmaceuticals to Publish Abstract at ASCO 2024
05 Apr 2024 //
GLOBENEWSWIRE
Lipella Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis
03 Apr 2024 //
GLOBENEWSWIRE
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410
05 Mar 2024 //
GLOBENEWSWIRE
Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference
20 Feb 2024 //
GLOBENEWSWIRE
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress
20 Dec 2023 //
GLOBENEWSWIRE
Lipella Pharmaceuticals Announces Closing of $2 Million Private Placement
25 Oct 2023 //
PR NEWSWIRE
Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference
23 Oct 2023 //
ACCESSWIRE
Lipella Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus
20 Oct 2023 //
PR NEWSWIRE
Lipella Pharmaceuticals` Phase 2a Clinical Study Results Published
21 Sep 2023 //
PR NEWSWIRE
Lipella Pharmaceuticals Reports 1Q 2023 FYR Results and Corporate Update
15 May 2023 //
PR NEWSWIRE
Lipella Pharmaceuticals Delivers Late-Breaking Presentation at the AUAAM
01 May 2023 //
PR NEWSWIRE
Lipella inks manufacturing collaboration agreement with Cook MyoSite
19 Apr 2023 //
PHARMABIZ
Lipella Pharmaceuticals Enters Manufacturing Collaboration Agreement
17 Apr 2023 //
PR NEWSWIRE
Lipella Pharmaceuticals, Cook MyoSite Enter Manufacturing Agreement
17 Apr 2023 //
CONTRACT PHARMA
Lipella Provides Business Update and Reports 2022 Financial Results
31 Mar 2023 //
PR NEWSWIRE
Lipella Pharmaceuticals Successfully Completes Phase 2a Clinical Trial
16 Mar 2023 //
PR NEWSWIRE
Lipella reports results from phase 2a of LP-10 for haemorrhagic cystitisn
13 Jan 2023 //
PHARMABIZ
Lipella Announces Closing of Initial Public Offering for Gross Proceeds of $7 M
22 Dec 2022 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.